Bridgewater Associates’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.7M Sell
98,627
-240,319
-71% -$90.7M 0.2% 84
2026
Q1
$100M Buy
338,946
+139,185
+70% +$38.8M 0.45% 38
2025
Q4
$38.7M Sell
199,761
-7,665
-4% -$1.32M 0.14% 116
2025
Q3
$28.6M Buy
+207,426
New +$22.7M 0.11% 148
2022
Q4
Sell
-10,870
Closed -$817K 928
2022
Q3
$817K Sell
10,870
-3,619
-25% -$330K ﹤0.01% 727
2022
Q2
$1.3M Sell
14,489
-32,650
-69% -$3.4M 0.01% 756
2022
Q1
$5.57M Buy
+47,139
New +$5.97M 0.02% 442
2021
Q3
Sell
-41,550
Closed -$5.57M 795
2021
Q2
$5.57M Buy
+41,550
New +$5.32M 0.04% 318
2021
Q1
Sell
-16,486
Closed -$1.98M 603
2020
Q4
$1.98M Buy
16,486
+4,183
+34% +$427K 0.02% 307
2020
Q3
$978K Buy
12,303
+9,845
+401% +$835K 0.01% 343
2020
Q2
$208K Buy
+2,458
New +$165K ﹤0.01% 373
2020
Q1
Sell
-7,109
Closed -$485K 581
2019
Q4
$485K Buy
+7,109
New +$451K 0.01% 419
2018
Q3
Sell
-9,397
Closed -$358K 472
2018
Q2
$358K Buy
+9,397
New +$366K ﹤0.01% 393

Other funds holding TER

Bridgewater Associates's TER Position: Q2 2026 in Review

Bridgewater Associates reduced its Teradyne (TER) stake by 71% in Q2 2026, selling an estimated $90.7M and leaving 98,627 shares worth $47.7M. The position accounts for 0.2% of the portfolio, ranked #84.

Bridgewater Associates first reported a position in TER in Q2 2018 and has held it in 13 quarters since. The position peaked at $100M in Q1 2026. 1,424 funds tracked by Wall St. Rank hold TER as of Q2 2026.

  • Bridgewater Associates held 98,627 shares of Teradyne worth $47.7M as of Q2 2026.
  • Bridgewater Associates sold 240,319 Teradyne shares in Q2 2026, an estimated $90.7M.
  • Teradyne made up 0.2% of Bridgewater Associates's portfolio in Q2 2026, its #84 holding.
  • Bridgewater Associates first reported a position in Teradyne in Q2 2018 and has held it in 13 quarters since.
  • Bridgewater Associates's Teradyne position peaked at $100M in Q1 2026.
  • 1,424 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.